Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Aug 26, 2019

Alexis Peyroles, CEO, OSE Immunotherapeutics talks about the important role the immune system plays in the development of a number of diseases.  OSE is a biotechnology company focused on the therapies that control the immune system for treatment of cancers and autoimmune diseases.  We discuss how drugs that regulate the...


Aug 26, 2019

Alexis Peyroles, CEO, OSE Immunotherapeutics talks about the important role the immune system plays in the development of a number of diseases.  OSE is a biotechnology company focused on the therapies that control the immune system for treatment of cancers and autoimmune diseases.  We discuss how drugs that regulate the...


Aug 7, 2019

Isaac Israel, CEO, Kitov Pharmaceuticals talks about how the development of new cancer treatments is an active and rapidly changing field and how Kitov is focusing on making cancer treatments more effective for patients.  They are developing combination therapies that can help overcome cancers' ability to develop...


Aug 7, 2019

Isaac Israel, CEO, Kitov Pharmaceuticals talks about how the development of new cancer treatments is an active and rapidly changing field and how Kitov is focusing on making cancer treatments more effective for patients.  They are developing combination therapies that can help overcome cancers' ability to develop...


Jun 25, 2019

Dr. Greg van Wyk, CMO and recently appointed CEO, Noxopharm talks about the Company's current milestones and upcoming news related to its lead clinical drug candidate, Veyonda, a chemotherapy and radiation enhancer that is being studied in men with late stage metastatic prostate cancer and that may have broad...